Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
NCT07021859

Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide

Led by Danish Headache Center · Updated on 2025-08-06

21

Participants Needed

1

Research Sites

78 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Calcitonin gene-related peptide (CGRP) is a key neuropeptide in migraine pathophysiology and treatment. This study investigates whether CGRP administration can trigger aura in individuals with a diagnosis of migraine with aura.

CONDITIONS

Official Title

Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to 65 years at screening
  • History of migraine with aura for 12 months or more according to ICHD-3 criteria
  • At least 1 monthly day with aura on average across the three months before screening
  • Signed informed consent before any study procedures
Not Eligible

You will not qualify if you...

  • Any primary or secondary headache disorder other than migraine with aura, migraine without aura, chronic migraine, or episodic tension-type headache
  • Any other significant medical condition that may risk safety or interfere with study participation
  • Risk of self-harm or harm to others based on past behavior
  • Positive pregnancy test in women of childbearing potential during study visits
  • Any cardiovascular or cerebrovascular disease
  • High blood pressure (systolic 6150 mmHg or diastolic 6100 mmHg) before infusion
  • Low blood pressure (systolic 490 mmHg or diastolic 450 mmHg)
  • Changes in prophylactic medication dosing within 2 months before study
  • Use of acute headache medications within 48 hours before infusion
  • Headache or aura occurring within 48 hours before infusion

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Rigshospitalet Glostrup

Glostrup Municipality, Denmark, 2600

Actively Recruiting

Loading map...

Research Team

H

Haidar Al-Khazali, MD

CONTACT

H

Hakan Ashina, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here